ARKG vs SHV
ARK Genomic Revolution ETF vs iShares Short Treasury Bond ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SHV—
iShares Short Treasury Bond ETF
US Treasuries maturing in under 1 year.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SHV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Holdings data unavailable for ARKG.
SHV top holdings
Holdings data unavailable for SHV.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SHV
SHV (iShares Short Treasury Bond ETF) is US Treasuries maturing in under 1 year.